The preventive effect of breast cancer drug 'tamoxifen' remains virtually constant for at least 20 years - with rates reduced by around 30 per cent - new analysis published in The Lancet Oncology reveals.
Dec 11, 2014
5 / 5 (1) | 0
Migraine was not associated with breast cancer risk or differences in the endogenous sex hormones that have been proposed to be associated with migraines, according to a new study published December 12 in the JNCI: Journal of ...
Dec 12, 2014
not rated yet | 0